(Q38198151)

30 August 2017

1 reference

title

Predictors of HIV-associated nephropathy (English)

1 reference

30 August 2017

Sana Waheed

1

1 reference

PubMed ID

24655211

30 August 2017

Mohamed G Atta

series ordinal

2

1 reference

30 August 2017

21 March 2014

1 reference

Expert Review of Anti-infective Therapy

30 August 2017

1 reference

30 August 2017

12

1 reference

30 August 2017

5

1 reference

30 August 2017

555-563

1 reference

Relationship between renal dysfunction, nephrotoxicity and death among HIV adults on tenofovir

30 August 2017

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.901170

Renal dysfunction in the setting of HIV/AIDS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.901170

Urinary albumin excretion within the normal range is an independent risk for near-term development of kidney disease in HIV-infected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.901170

Pre-existing albuminuria predicts AIDS and non-AIDS mortality in women initiating antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.901170

Kidney function and the risk of cardiovascular events in HIV-1-infected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.901170

Incidence and etiology of acute renal failure among ambulatory HIV-infected patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.901170

Nephropathy in the context of HIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.901170

Pattern of glomerular involvement in human immunodeficiency virus-infected patients: an Italian study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.901170

Comparison of risk factors and outcomes in HIV immune complex kidney disease and HIV-associated nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.901170

Thrombotic microangiopathies and HIV infection: report of two typical cases, features of HUS and TTP, and review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.901170

Manifestations resembling thrombotic microangiopathy in patients with advanced human immunodeficiency virus (HIV) disease in a cytomegalovirus prophylaxis trial (ACTG 204).

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.901170

HIV-associated thrombotic microangiopathy in the era of highly active antiretroviral therapy: an observational study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.901170

Human immunodeficiency virus-associated thrombotic microangiopathies: clinical characteristics and outcome according to ADAMTS13 activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.901170

The nephrotoxic effects of HAART.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.901170

Antiretroviral nephrotoxicities

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.901170

ASN clinical pathological conference. Tenofovir-related ATN (severe).

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.901170

Tenofovir-associated kidney toxicity in HIV-infected patients: a review of the evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.901170

Tenofovir-induced kidney injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.901170

Renal toxicity associated with tenofovir use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.901170

Association of tenofovir exposure with kidney disease risk in HIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.901170

Ritonavir-boosted atazanavir exposure is associated with an increased rate of renal stones compared with efavirenz, ritonavir-boosted lopinavir and ritonavir-boosted darunavir

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.901170

Estimated glomerular filtration rate, chronic kidney disease and antiretroviral drug use in HIV-positive patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.901170

The quad pill, a once-daily combination therapy for HIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.901170

Dolutegravir, a second-generation integrase inhibitor for the treatment of HIV-1 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.901170

Associated focal and segmental glomerulosclerosis in the acquired immunodeficiency syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.901170

End-stage renal disease and chronic kidney disease in a cohort of African-American HIV-infected and at-risk HIV-seronegative participants followed between 1988 and 2004.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.901170

HIV-associated nephropathy: epidemiology, pathogenesis, diagnosis and management

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.901170

HIV-associated nephropathy: case study and review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.901170

Nephropathy in human immunodeficiency virus-1 transgenic mice is due to renal transgene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.901170

HIV-associated nephropathy: pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.901170

Diagnosis and natural history of HIV-associated nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.901170

MicroRNAs in HIV-associated nephropathy (HIVAN).

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.901170

Persistent NF-kappaB activation in renal epithelial cells in a mouse model of HIV-associated nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.901170

HIV-1 upregulates VEGF in podocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.901170

Tracing the origin of glomerular extracapillary lesions from parietal epithelial cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.901170

HIV-associated kidney glomerular diseases: changes with time and HAART.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.901170

Presentation of HIV-associated nephropathy and outcome in HAART-treated patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.901170

Association of trypanolytic ApoL1 variants with kidney disease in African Americans

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.901170

APOL1 variants increase risk for FSGS and HIVAN but not IgA nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.901170

APOL1 genetic variants in focal segmental glomerulosclerosis and HIV-associated nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.901170

Identifying Darwinian selection acting on different human APOL1 variants among diverse African populations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.901170

HIV-associated nephropathy patients with and without apolipoprotein L1 gene variants have similar clinical and pathological characteristics

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.901170

APOL1 variants in HIV-associated nephropathy: just one piece of the puzzle

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.901170

Presentation, pathology, and outcome of HIV associated renal disease in a specialist centre for HIV/AIDS

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.901170

HIV type 1 RNA level as a clinical indicator of renal pathology in HIV-infected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.901170

A cross-sectional study of HIV-seropositive patients with varying degrees of proteinuria in South Africa

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.901170

Sonography as a predictor of human immunodeficiency virus-associated nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.901170

Diagnostic sonography of HIV-associated nephropathy: new observations and clinical correlation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.901170

Association of parvovirus B19 infection with idiopathic collapsing glomerulopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.901170

Focal segmental glomerulosclerosis plays a major role in the progression of IgA nephropathy. II. Light microscopic and clinical studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.901170

Effect of inhibitors of the renin-angiotensin system and other antihypertensive drugs on renal outcomes: systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.901170

The beneficial effect of angiotensin-converting enzyme inhibition with captopril on diabetic nephropathy in normotensive IDDM patients with microalbuminuria. North American Microalbuminuria Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.901170

Expert opinion on pharmacotherapy of kidney disease in HIV-infected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.901170

Captopril and renal survival in patients with human immunodeficiency virus nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.901170

Long-term renal survival in HIV-associated nephropathy with angiotensin-converting enzyme inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.901170

Clinicopathologic correlates of prednisone treatment of human immunodeficiency virus-associated nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.901170

Prednisone improves renal function and proteinuria in human immunodeficiency virus-associated nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.901170

Cohort study of the treatment of severe HIV-associated nephropathy with corticosteroids

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.901170

Survival during renal replacement therapy among African Americans infected with HIV type 1 in urban Baltimore, Maryland

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.901170

Hemodialysis access: influence of the human immunodeficiency virus on patency and infection rates

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.901170

Arteriovenous access outcomes in haemodialysis patients with HIV infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.901170

Epidemic transmission of human immunodeficiency virus in renal dialysis centers in Egypt.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.901170

Pseudomonal and candidal peritonitis as a complication of continuous ambulatory peritoneal dialysis in human immunodeficiency virus-infected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.901170

HIV-positive renal recipients can achieve survival rates similar to those of HIV-negative patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.901170

HIV-infected liver and kidney transplant recipients: 1- and 3-year outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.901170

Outcomes of kidney transplantation in HIV-infected recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.901170

Predictors of complication after percutaneous ultrasound-guided kidney biopsy in HIV-infected individuals: possible role of hepatitis C and HIV co-infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.901170

Serious Fatal and Nonfatal Non-AIDS-Defining Illnesses in Europe

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.901170

Tenofovir-induced renal toxicity in 324 HIV-infected, antiretroviral-naïve patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.901170

10.1586/14787210.2014.901170

21 January 2018

Identifiers

DOI

1 reference

30 August 2017

1 reference

PubMed ID

24655211